# Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial

Study · id `cardio:ct-nct01979744` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01979744](<https://clinicaltrials.gov/study/NCT01979744>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01979744

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 568 participants.

## Technical summary

Registry record NCT01979744. Randomized; no masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2017-10-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 568 participants (enrolled count; ClinicalTrials.gov record NCT01979744, source copy `cardio:ctgov-nct01979744-2019-03-28`, retrieved 2026-10-26)
- Start date: 2013-10 (registry gives no type) (ClinicalTrials.gov record NCT01979744, source copy `cardio:ctgov-nct01979744-2019-03-28`, retrieved 2026-10-26)
- Primary completion: 2017-10-31 (actual) (ClinicalTrials.gov record NCT01979744, source copy `cardio:ctgov-nct01979744-2019-03-28`, retrieved 2026-10-26)
- Completion: 2017-10-31 (actual) (ClinicalTrials.gov record NCT01979744, source copy `cardio:ctgov-nct01979744-2019-03-28`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01979744, source copy `cardio:ctgov-nct01979744-2019-03-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01979744-2019-03-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial
- Condition: Coronary Artery Disease
- Intervention (Procedure): IVUS guided percutaneous coronary angioplasty with Resolute integrity stent insertion
- Intervention (Device): Angiography guided percutaneous coronary angioplasty with Resolute integrity stent insertion
- Intervention (Device): Angiography guided percutaneous coronary angioplasty with Promus element stent implantation
- Intervention (Procedure): Angiography guided percutaneous coronary angioplasty with Promus element stent implantation
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: cb6aa41dc0a49ce15cab165937086740b8a674afc813afa3444326edf5a72023
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
